NEO2IS can also reflect clinical features (tumor size and metastasis), implying progressive T cell dysfunction at advanced stage of tumors and terminal differentiation of CD8+ Tex under constantly elevated antigenic exposure in tumors. This evidence concerns the gene CD8A and neoplasm.